Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-26

Clinical Trial Update: TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating the combination of transarterial chemoembolization (TACE) with lenvatinib and microwave ablation (MWA) for locally advanced large hepatoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenvatinib (lenvatinib)
  • MWA
  • TACE

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Tumor | Phase 2 | Status: UNKNOWN